In a recent first-in-human study, a 89Zr-labeled anti-CD8 minibody was used to detect CD8+ T cell tumor infiltrates in patients with hepatocellular carcinoma, melanoma, and lung cancer (89Zr-labeled-IAB22M2C) 79. Here, CD8A is linked to lung cancer.